COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2594: Articles 25931-25940  | Next

A model of COVID-19 transmission and control on university campuses
Lopman, B., Liu, C., Le Guillou, A., Lash, T. L., Isakov, A., Jenness, S.
10.1101/2020.06.23.20138677 — Posted: 2020-06-24
Only a combination of social distancing and massive testing can effectively stop COVID-19 progression in densely populated urban areas
Alvarez, M. M., Trujillo-de Santiago, G.
10.1101/2020.06.23.20138743 — Posted: 2020-06-24 Discussion: Onsite
Initial experience with short-course corticosteroids in a small cohort of adults with severe COVID-19 in a tertiary care hospital in India
Jha, S., Shetty, K., Vadi, S., Phadtare, S., Raut, A., Shah, S., Bhargava, P., Singhal, T.
10.1101/2020.06.23.20137471 — Posted: 2020-06-24
Longitudinal immunological analyses reveal inflammatory misfiring in severe COVID-19 patients
Lucas, C., Wong, P., Klein, J., Castro, T., Silva, J., Sundaram, M., Ellingson, M., Mao, T., Oh, J., Israelow, B., Tokuyama, M., Lu, P., Venkataraman, A., Park, A., Mohanty, S., Wang, H., Wyllie, A. L., Vogels, C. B. F., Earnest, R., Lapidus, S., Ott, I., Moore, A., Muenker, C., Fournier, J., Campbell, M., Odio, C., Casanovas-Massana, A., Yale IMPACT Team, , Herbst, R., Shaw, A., Medzhitov, R., Schulz, W. L., Grubaugh, N., Dela Cruz, C., Farhadian, S., Ko, A., Omer, S., Iwasaki, A.
10.1101/2020.06.23.20138289 — Posted: 2020-06-24 Discussion: Onsite | Offsite
Breath-borne VOC Biomarkers for COVID-19
Chen, H., Qi, X., Ma, J., Zhang, C., Feng, H., Yao, M.
10.1101/2020.06.21.20136523 — Posted: 2020-06-24
Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020
Feehan, A. K., Fort, D., Garcia-Diaz, J., Price-Haywood, E., Velasco, C., Sapp, E., Pevey, D., Seoane, L.
10.1101/2020.06.23.20138321 — Posted: 2020-06-24
Scalable, rapid and highly sensitive isothermal detection of SARS-CoV-2 for laboratory and home testing
Kellner, M. J., Ross, J. J., Schnabl, J., Dekens, M. P. S., Heinen, R., Tanner, N. A., Fritsche-Polanz, R., Traugott, M., Seitz, T., Zoufaly, A., Foedinger, M., Wenisch, C., Zuber, J., Vienna Covid-19 Diagnostics Initiative (VCDI), , Pauli, A., Brennecke, J.
10.1101/2020.06.23.166397 — Posted: 2020-06-23 Discussion: Onsite | Offsite
BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden.
de Chaisemartin, C., de Chaisemartin, L.
10.1101/2020.06.22.20137802 — Posted: 2020-06-23 Discussion: Onsite
Logistic Approach to COVID - 19 Epidemic Evolution in Brazil
DE ASSIS, A. S., de Carvalho, V. J.
10.1101/2020.06.22.20135921 — Posted: 2020-06-23
Modeling the effect of COVID-19 disease on the cardiac function: a computational study
Regazzoni, F., Vergara, C., Dede', L., Zunino, P., Guglielmo, M., Scrofani, R., Fusini, L., Cogliati, C., Pontone, G., Quarteroni, A.
10.1101/2020.06.23.166421 — Posted: 2020-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).